加味丹参饮诱导骨髓间充质干细胞分化为心肌样细胞的研究
|
摘要
目的：
探讨加味丹参饮(Jia Wei Dan Shen Yin JWDSY)在体外能否诱导骨髓间充质干细胞(bone mesenchymal stem cells BMSCs)向心肌样细胞分化,以及JWDSY对BMSCs移植心肌梗死心血瘀阻型大鼠心肌的作用。
方法：
实验一：采用全骨髓贴壁法培养大鼠BMSCs,并进行传代、扩增,对细胞形态学和生长特性进行观察,通过流式细胞术对细胞表面抗原CD90、CD11b、CD45进行表型鉴定。采用水提醇沉法制备JWDSY的提取物并通过MTT法检测不同浓度JWDSY提取物对BMSCs的毒性作用及增殖的影响。
实验二：体外诱导BMSCs,将培养的BMSCs分为4组：正常对照组、5-Aza组、JWDSY组和JWDSY+5-Aza组进行诱导分化。通过免疫组化的方法检测心肌细胞特有的结蛋白Desmin、肌球蛋白MHC和肌钙蛋白T的表达,用RT-PCR的方法检测心肌转录因子GATA-4 mRNA的表达。实验三：建立大鼠急性心梗心血瘀阻模型,正常组大鼠10只,60只造模成功大鼠分为4个组：模型组、JWDSY组、BMSCs组和JWDSY+BMSCs组。移植28d后,免疫组化双染法检测大鼠心肌组织中心肌结蛋白Desmin和肌球蛋白重链MHC的表达,Masson三色染色法检测大鼠心肌组织心室肌瘢痕面积百分比和心肌血管新生情况,RT-PCR法检测大鼠心肌组织中心肌细胞转录因子GATA-4 mRNA的表达。
结果：
实验一：经流式细胞术鉴定通过全骨髓贴壁法培养的BMSCs纯度较高,细胞表面抗原CD90阳性细胞达到95%以上,CD11b和CD45阳性细胞小于5%,符合实验要求。MTT结果显示,0.625mg/mL的JWDSY为进行BMSCs诱导的工作浓度。
实验二：体外对BMSCs进行诱导后,正常对照组中未发现MHC、Desmin知CTnT阳性细胞；JWDSY组、5-Aza组和JWDSY+5-Aza组免疫组化染色均可见阳性免疫复合物。经JWDSY+5-Aza联合诱导后的BMSCs其MHC表达量高于JWDSY组和5-Aza组,差异有统计学意义(P<0.05),JWDSY组与5-Aza组两组间差异无统计学意义(P>0.05)。经JWDSY+5-Aza联合诱导后的BMSCs其Desmin表达量高于JWDSY组和5-Aza组,差异有统计学意义(P<0.05),JWDSY组与5-Aza组两组间差异无统计学意义(P>0.05)。经JWDSY+5-Aza联合诱导后的BMSCs其CTnT表达量高于JWDSY组和5-Aza组,差异有统计学意义(P<0.05),JWDSY组与5-Aza组两组间差异无统计学意义(P>0.05)。JWDSY+5-Aza组、JWDSY组和5-Aza组GATA-4 mRNA相对光密度值与正常对照组比较差异具有统计学意义(P<0.05)。
实验三：移植后28d,Masson染色切片结果显示,正常组未见梗死灶和纤维形成,其余各组均出现大小不等的梗死灶,JWDSY组+BMSCs组、JWDSY组和BMSCs组的心室肌瘢痕面积百分比均较模型组显著减小(P<0.01)；JWDSY组+BMSCs组较JWDSY组和BMSCs组瘢痕面积百分比显著减小(P<0.05),JWDSY组和BMSCs组两者之间比较,无显著差异(P>0.05)。与正常组比较,各造模组的心肌毛细血管数均增高,差异有统计学意义(P<0.05)。JWDSY组、BMSCs组和JWDSY+BMSCs组的心肌毛细血管数较模型组显著增加(P<0.01)；JWDSY+BMSCs组与JWDSY组和BMSCs组比较,心肌毛细血管数增加有显著性意义(P<0.05),JWDSY组和BMSCs组两者之间比较,差异无显著性意义(P>0.05)。在模型组和JWDSY组梗死边缘未见有MHC-Brdu、Desmin-Brdu双染表达；BMSCs组和JWDSY+BMSCs组均可见猩红色Brdu抗体着色和棕色MHC蛋白的同时表达以及猩红色Brdu抗体着色和棕色Desmin蛋白的同时表达。JWDSY+BMSCs组的阳性细胞计数高于BMSCs组(P<0.05)。RT-PCR检测GATA-4 mRNA的表达结果显示,正常组和模型组未见到阳性条带,JWDSY组阳性条带较弱,BMSCs组和JWDSY+BMSCs组可见阳性条带,对其IOD值半定量分析JWDSY+BMSCs组高于BMSCs组(P<0.05)。
结论：
(1)JWDSY在体外能促进BMSCs向心肌样细胞分化,并可以加强5-Aza诱导BMSCs向心肌样细胞分化的作用。
(2)在心梗心血瘀阻证大鼠模型中JWDSY组、BMSCs组和JWDSY+BMSCs均能促进新生血管,增加移植细胞的血供,能缩小梗死面积。而JWDSY能促进BMSCs移植后的血管新生和减少瘢痕形成。
(3)在心梗心血瘀阻证大鼠模型中JWDSY能促进移植的BMSCs向心肌样细胞分化,JWDSY与BMSCs移植联合应用的疗效较单用更佳。
Objective:
To explore the differentiation possibility of bone mesenchymal stem cells (BMMSCs) into myocardium-like cell induced by Jia Wei Dan Shen Yin(JWDSY) in vitro as well as therapeutic effects made by JWDSY on rats in cardiac blood stasis syndrome present with myocardial infarction after BMMSCs transplantation.
Methods:
Test 1:Cultivate BMMSCs of rats by bone marrow adherent method, perform passage culture and amplification, inspect cellular morphology and growth characteristics, analysize phenotypes of CD90, CD11b, CD45 with flow cytometer. Prepare extractive of JWDSY with decoction and alcohol sedimentation technique, test toxic effect and proliferation of BMMSCs affected by different JWDSY concentrations in MTT way.
Test 2:Induce BMMSCs in vitro, divide them into 4 groups:normal control group,5-Aza group, JWDSY group as well as combined JWDSY and 5-Aza group, induce their differentiation. Detect expressions of peculiar cardiomyocyte bindin Desmin, myosin MHC along with troponin T by immunohistochemistry approaches, check myocardial transcription factor GATA-4 mRNA expression with RT-PCR.
Test 3:Set up acute myocardial infarction model in cardiac blood stasis syndrome of the rats, group 60 successfully molded rats into model set, JWDSY group, BMSCs group and combined JWDSY and BMSCs group beyond 10 normal rats. Observe expressions of myocardial bindin Desmin and myosin heavy chain(MHC) in rats' myocardial tissues with double staning immunohistochemical way 28 days after transplantation. Masson trichrome staning is employed in evaluations of ventricular scar proportion and myocardial angiogenesis in myocardial tissues of the rats, take RT-PCR to measure myocardiocyte expression of GATA-4 mRNA.
Results:
Test 1:Flow cytometry evaluated that BMSCs fineness by panmyelo-adherent culture was higher, positive cell surface antigen CD90 was above 95% while positive CD11b and CD45 cells were below 5% which fit the experiment requirement. MTT outcomes revealed that 0.625mg/ml JWDSY was optimal concentration for proliferation of BMMSCs.
Test 2:MHC, Desmin and CTnT positive cells were absent in normal control group after in vitro BMMSCs induction by JWDSY; whereas positive immunocomplex were present in JWDSY group,5-aza group and combined JWDSY and 5-aza group in immunohistochemical stainig. MHC expression induced by combined JWDSY and 5-Aza group was greater than two single ones, the difference has statistical significance (P<0.05), but there was no statistical significance between the two single groups(P>0.05), so did Desmin and CTnT. Significant statistical differences of relative optical density values of GATA-4 mRNA existed in combined JWDSY and 5-Aza group, JWDSY group and 5-aza group compared to the normal control group (P<0.05).
Test 3:Twenty-eight days after transplant, Masson stained slices results suggested that neither infarct locus nor fiber is present in normal control group, while infarctions with different sizes appeared in other groups, ventricle muscular scar areas of combined JWDSY and BMSCs group, JWDSY group and BMSCs group showed notable decreases than model group all(P<0.01); in addition, the combined group performed a more significant scar area proportion decline rather than the two later groups(P<0.05), but the apparent differences were absent between the two single groups(P>0.05).The amount of myocardial blood capillary of every model group elevated compared to the control group with statistical significance (P<0.05). JWDSY group, BMSCs group and the combined group obtained remarkable increases than model group(P<0.01); compared with the two single group, the combined group revealed a significant statistics difference(P<0.05). No distinct significance existed in the two former group. Associated MHC-Brdu and Desmin-Brdu expression was unseen either in the model group or the JWDSY group; but scarlet Bru antibody and brown MHC protein dyes were available in infarct edge of both model group and JWDSY group as well as simultaneous expressions of scarlet Brdu antibody dye and brown Desmin protein. Positive cell count in combined group was greater than BMSCs group (P<.05). Positive stripe was absent in model group or control group after RT-PCR detection for GATA-4 expressions, but present in BMSCs group and the combined group and it was lesser in JWDSY group, what's more,the combined group was higher than the BMSCs group by semi quantitative analysis of IOD value(P<0.05).
Conclusions:
(1) JWDSY is able to promote myocardium-like differentiation of BMSCs in vitro and subserve 5-Aza to induce myocardium-like differentiation of BMSCs.
(2) In rat models present with myocardial infarction and cardiac blood stasis syndrome, JWDSY group, BMSCs group and combined BMSCs and JWDSY group are all capable to promote vascular neogenesis, increase blood supply of transplanted cells, and shrink infarct area. JWDSY can precipitate angiogenesis after BMSCs transplant, and reduce cicatrization.
(3)JWDSY is able to promote myocardium-like differentiation of BMSCs in cardiac blood stasis syndrome rat models present with myocardial infarction, Combined JWDSY and BMSCs transplant showed a better therapeutic effect than single use of each approach.
探讨加味丹参饮(Jia Wei Dan Shen Yin JWDSY)在体外能否诱导骨髓间充质干细胞(bone mesenchymal stem cells BMSCs)向心肌样细胞分化,以及JWDSY对BMSCs移植心肌梗死心血瘀阻型大鼠心肌的作用。
方法：
实验一：采用全骨髓贴壁法培养大鼠BMSCs,并进行传代、扩增,对细胞形态学和生长特性进行观察,通过流式细胞术对细胞表面抗原CD90、CD11b、CD45进行表型鉴定。采用水提醇沉法制备JWDSY的提取物并通过MTT法检测不同浓度JWDSY提取物对BMSCs的毒性作用及增殖的影响。
实验二：体外诱导BMSCs,将培养的BMSCs分为4组：正常对照组、5-Aza组、JWDSY组和JWDSY+5-Aza组进行诱导分化。通过免疫组化的方法检测心肌细胞特有的结蛋白Desmin、肌球蛋白MHC和肌钙蛋白T的表达,用RT-PCR的方法检测心肌转录因子GATA-4 mRNA的表达。实验三：建立大鼠急性心梗心血瘀阻模型,正常组大鼠10只,60只造模成功大鼠分为4个组：模型组、JWDSY组、BMSCs组和JWDSY+BMSCs组。移植28d后,免疫组化双染法检测大鼠心肌组织中心肌结蛋白Desmin和肌球蛋白重链MHC的表达,Masson三色染色法检测大鼠心肌组织心室肌瘢痕面积百分比和心肌血管新生情况,RT-PCR法检测大鼠心肌组织中心肌细胞转录因子GATA-4 mRNA的表达。
结果：
实验一：经流式细胞术鉴定通过全骨髓贴壁法培养的BMSCs纯度较高,细胞表面抗原CD90阳性细胞达到95%以上,CD11b和CD45阳性细胞小于5%,符合实验要求。MTT结果显示,0.625mg/mL的JWDSY为进行BMSCs诱导的工作浓度。
实验二：体外对BMSCs进行诱导后,正常对照组中未发现MHC、Desmin知CTnT阳性细胞；JWDSY组、5-Aza组和JWDSY+5-Aza组免疫组化染色均可见阳性免疫复合物。经JWDSY+5-Aza联合诱导后的BMSCs其MHC表达量高于JWDSY组和5-Aza组,差异有统计学意义(P<0.05),JWDSY组与5-Aza组两组间差异无统计学意义(P>0.05)。经JWDSY+5-Aza联合诱导后的BMSCs其Desmin表达量高于JWDSY组和5-Aza组,差异有统计学意义(P<0.05),JWDSY组与5-Aza组两组间差异无统计学意义(P>0.05)。经JWDSY+5-Aza联合诱导后的BMSCs其CTnT表达量高于JWDSY组和5-Aza组,差异有统计学意义(P<0.05),JWDSY组与5-Aza组两组间差异无统计学意义(P>0.05)。JWDSY+5-Aza组、JWDSY组和5-Aza组GATA-4 mRNA相对光密度值与正常对照组比较差异具有统计学意义(P<0.05)。
实验三：移植后28d,Masson染色切片结果显示,正常组未见梗死灶和纤维形成,其余各组均出现大小不等的梗死灶,JWDSY组+BMSCs组、JWDSY组和BMSCs组的心室肌瘢痕面积百分比均较模型组显著减小(P<0.01)；JWDSY组+BMSCs组较JWDSY组和BMSCs组瘢痕面积百分比显著减小(P<0.05),JWDSY组和BMSCs组两者之间比较,无显著差异(P>0.05)。与正常组比较,各造模组的心肌毛细血管数均增高,差异有统计学意义(P<0.05)。JWDSY组、BMSCs组和JWDSY+BMSCs组的心肌毛细血管数较模型组显著增加(P<0.01)；JWDSY+BMSCs组与JWDSY组和BMSCs组比较,心肌毛细血管数增加有显著性意义(P<0.05),JWDSY组和BMSCs组两者之间比较,差异无显著性意义(P>0.05)。在模型组和JWDSY组梗死边缘未见有MHC-Brdu、Desmin-Brdu双染表达；BMSCs组和JWDSY+BMSCs组均可见猩红色Brdu抗体着色和棕色MHC蛋白的同时表达以及猩红色Brdu抗体着色和棕色Desmin蛋白的同时表达。JWDSY+BMSCs组的阳性细胞计数高于BMSCs组(P<0.05)。RT-PCR检测GATA-4 mRNA的表达结果显示,正常组和模型组未见到阳性条带,JWDSY组阳性条带较弱,BMSCs组和JWDSY+BMSCs组可见阳性条带,对其IOD值半定量分析JWDSY+BMSCs组高于BMSCs组(P<0.05)。
结论：
(1)JWDSY在体外能促进BMSCs向心肌样细胞分化,并可以加强5-Aza诱导BMSCs向心肌样细胞分化的作用。
(2)在心梗心血瘀阻证大鼠模型中JWDSY组、BMSCs组和JWDSY+BMSCs均能促进新生血管,增加移植细胞的血供,能缩小梗死面积。而JWDSY能促进BMSCs移植后的血管新生和减少瘢痕形成。
(3)在心梗心血瘀阻证大鼠模型中JWDSY能促进移植的BMSCs向心肌样细胞分化,JWDSY与BMSCs移植联合应用的疗效较单用更佳。
Objective:
To explore the differentiation possibility of bone mesenchymal stem cells (BMMSCs) into myocardium-like cell induced by Jia Wei Dan Shen Yin(JWDSY) in vitro as well as therapeutic effects made by JWDSY on rats in cardiac blood stasis syndrome present with myocardial infarction after BMMSCs transplantation.
Methods:
Test 1:Cultivate BMMSCs of rats by bone marrow adherent method, perform passage culture and amplification, inspect cellular morphology and growth characteristics, analysize phenotypes of CD90, CD11b, CD45 with flow cytometer. Prepare extractive of JWDSY with decoction and alcohol sedimentation technique, test toxic effect and proliferation of BMMSCs affected by different JWDSY concentrations in MTT way.
Test 2:Induce BMMSCs in vitro, divide them into 4 groups:normal control group,5-Aza group, JWDSY group as well as combined JWDSY and 5-Aza group, induce their differentiation. Detect expressions of peculiar cardiomyocyte bindin Desmin, myosin MHC along with troponin T by immunohistochemistry approaches, check myocardial transcription factor GATA-4 mRNA expression with RT-PCR.
Test 3:Set up acute myocardial infarction model in cardiac blood stasis syndrome of the rats, group 60 successfully molded rats into model set, JWDSY group, BMSCs group and combined JWDSY and BMSCs group beyond 10 normal rats. Observe expressions of myocardial bindin Desmin and myosin heavy chain(MHC) in rats' myocardial tissues with double staning immunohistochemical way 28 days after transplantation. Masson trichrome staning is employed in evaluations of ventricular scar proportion and myocardial angiogenesis in myocardial tissues of the rats, take RT-PCR to measure myocardiocyte expression of GATA-4 mRNA.
Results:
Test 1:Flow cytometry evaluated that BMSCs fineness by panmyelo-adherent culture was higher, positive cell surface antigen CD90 was above 95% while positive CD11b and CD45 cells were below 5% which fit the experiment requirement. MTT outcomes revealed that 0.625mg/ml JWDSY was optimal concentration for proliferation of BMMSCs.
Test 2:MHC, Desmin and CTnT positive cells were absent in normal control group after in vitro BMMSCs induction by JWDSY; whereas positive immunocomplex were present in JWDSY group,5-aza group and combined JWDSY and 5-aza group in immunohistochemical stainig. MHC expression induced by combined JWDSY and 5-Aza group was greater than two single ones, the difference has statistical significance (P<0.05), but there was no statistical significance between the two single groups(P>0.05), so did Desmin and CTnT. Significant statistical differences of relative optical density values of GATA-4 mRNA existed in combined JWDSY and 5-Aza group, JWDSY group and 5-aza group compared to the normal control group (P<0.05).
Test 3:Twenty-eight days after transplant, Masson stained slices results suggested that neither infarct locus nor fiber is present in normal control group, while infarctions with different sizes appeared in other groups, ventricle muscular scar areas of combined JWDSY and BMSCs group, JWDSY group and BMSCs group showed notable decreases than model group all(P<0.01); in addition, the combined group performed a more significant scar area proportion decline rather than the two later groups(P<0.05), but the apparent differences were absent between the two single groups(P>0.05).The amount of myocardial blood capillary of every model group elevated compared to the control group with statistical significance (P<0.05). JWDSY group, BMSCs group and the combined group obtained remarkable increases than model group(P<0.01); compared with the two single group, the combined group revealed a significant statistics difference(P<0.05). No distinct significance existed in the two former group. Associated MHC-Brdu and Desmin-Brdu expression was unseen either in the model group or the JWDSY group; but scarlet Bru antibody and brown MHC protein dyes were available in infarct edge of both model group and JWDSY group as well as simultaneous expressions of scarlet Brdu antibody dye and brown Desmin protein. Positive cell count in combined group was greater than BMSCs group (P<.05). Positive stripe was absent in model group or control group after RT-PCR detection for GATA-4 expressions, but present in BMSCs group and the combined group and it was lesser in JWDSY group, what's more,the combined group was higher than the BMSCs group by semi quantitative analysis of IOD value(P<0.05).
Conclusions:
(1) JWDSY is able to promote myocardium-like differentiation of BMSCs in vitro and subserve 5-Aza to induce myocardium-like differentiation of BMSCs.
(2) In rat models present with myocardial infarction and cardiac blood stasis syndrome, JWDSY group, BMSCs group and combined BMSCs and JWDSY group are all capable to promote vascular neogenesis, increase blood supply of transplanted cells, and shrink infarct area. JWDSY can precipitate angiogenesis after BMSCs transplant, and reduce cicatrization.
(3)JWDSY is able to promote myocardium-like differentiation of BMSCs in cardiac blood stasis syndrome rat models present with myocardial infarction, Combined JWDSY and BMSCs transplant showed a better therapeutic effect than single use of each approach.
引文
[1]Beltrami AP, Mrbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med,2001,344(23):1750-1757.
[2]Quaini F, Mrbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med,2002,346 (1):5-15.
[3]Lev S,Kehat L,GePstein L.Differentiation pathways in human embryonic stem cell derived cardiomyocytes [J]. Ann NY Aead Sci,2005,1047(1):50-65.
[4]Planat-Benard V,Menard C,Andre M,et al. Spontaneous cardio-myocyte differentiation from adipose tissue stroma cells.Cir Res,2004,943:223-229.
[5]张近宝,顾春虎,刘维水,等.犬骨髓间充质干细胞可诱导分化为组织工程瓣间质种子细胞[J].心脏杂志,2006；18(5)：489-491、495.
[6]Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002,418:41-49.
[7]Yoon YS,Wecker A, Heyd L, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest,2005, 115:326-338.
[8]Valiunas V, Doronin S, Valiuniene L, et a 1. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol,2004,555:617-626.
[9]党懿,齐晓勇,孟存良,等.骨髓间充质干细胞体外诱导培养后的电生理特性.[J]中国组织工程研究与临床康复,2009；13(27)：5261-5264.
[10]霍艳明,郭维琴,戴雁彦,等.益气活血化瘀法在急性心肌梗塞中的应用[J].北京中医药大学学报,1999,22(2)：46-47.
[11]周小青,王大安,肖雅,等.活血化瘀类方抗急性心肌缺血的实验研究.中西医结合心脑血管病杂志,2003,1(4)：187-188.
[12]杨祖福,胡婉英,秦志强,等.双龙丸对实验性大鼠心肌梗死血管新生的影响与分子学机制[J].中国康复理论与实践,2003,9(5)：293-295.
[13]裴雪涛主编.干细胞生物学[M],北京：科学出版社,2003：4-7.
[14]Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe post infarction left ventricular dysfunction[J].J Am Cell Cardiol,2003,41 (7): 1078-1083.
[15]Colter DC, Class R, Digirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow[J]. Proc Natl Acad Sci MSA,2000,97 (7):3213-3218
[16]Muraglia A,Cancedda R,Quarto R.Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci,2000,113:1161-1166.
[17]马力,刘大军,李德天,等.不同分离方法及培养条件对兔骨髓间充质干细胞生长增殖及生物学特性的影响[J].中国组织工程研究与临床康复,2008,12(38)：7401-7406.
[18]中华人民共和国科学技术部.关于善待实验动物的指导性意见2006-09-30.
[19]Friedenstein AJ,Petrakova KV, Kurolesova AI,et al. Hetero-topic of bone marrow:Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation,1968, 6(2):230-247.
[20]Friedenstein AJ. Precursor cells of mechanocytes. Int Revctol, 1976,47:327-355.
[21]Krause DS. Bone marrow derived cells and stem cells in lung repair[J]. Proc Am Thorac Soc,2008,5:323-327.
[22]Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature,2004,428 (6983):668—673.
[23]Murry CE, Soonpaa MH, Reineeke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature,2004,28 (6983):664-668.
[24]Keiichi F, Shinsuke Y. Stem cells as a source of regenerative cardiomyocytes[J]. Circ Res,2006,4:1002-1013.
[25]Tan SCW, Pan WX, Ma G, et al. Viscoelastic behavior of human mesenchymal stem cells[J]. BMC Cell Biol,2008,9:40-47.
[26]Summer R,Fine A. Mesenchymal progenitor cell research: limitations and recommendations[J]. Proc Am Thorac Soc,2008, 5:707-710.
[27]Zhang S, Ge J, Sun A, et al. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem,2006,99 (4): 1132-1147.
[28]Morito T,Munetal T, Hara K, et al. Synovial fluid-derived mesenchymal stem cells increase after intra-articular ligament injury in humans[J]. Rheumatology,2008,47:1137-1143.
[29]卢新政,张晓文,黄峻,等.大鼠骨髓间充质干细胞培养方法的改良[J].中国心血管杂志,2004,9(1)：48-51.
[30]Conge t PA, Minguell JJ. Pheno typical and functional properties of human bone marrow mesenchymal progenitor cells[J],J Cell Physiol,1999,181(1):63-73.
[31]Secco M, Zucconi E, Vieira NM, et al. Mul tipotent stem cells from umbilical cord:cord is richer than blood!Stem Cells,2008, 26(1):146-150.
[32]Peister A,Mellad JA, Wang M, et al. Stable transfection of MSCs by electroporation. Gene Ther,2004,11 (2) 224-228.
[33]Jones E, Mcgonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford),2008,47 (2):126-131.
[34]Liu Y, Song J,Liu X, et al. Growth and differentiation of rat bone marrow stromal cells:does 5-azacytidine trigger their cardiomyo-genie differentiation. Cardiovasc,2003,58 (2):460-468.
[35]王跃春,张洹.人胎骨髓MSCs的分离鉴定及其向肝细胞样的分化[J].中国病理生理杂志,2007,23(11)：2205-2209.
[36]戴文达,方涛林,李熙雷,等.人骨髓间充质干细胞的分离培养、多向分化与鉴定[J].复旦学报,医学版,2008,35(3)：448-452.
[37]Yoshimura H, Muneta T, Nimura A, et al. Comparison of rat mesenchymal stem cells derived from bone marrow. synovium, periosteum, adipose tissue and muscle[J].Cell Tissue Res, 2007,327 (3):449-462.
[38]司徒镇强,吴正军.细胞培养[M].西安：世界图书出版社,2007：250.
[39]张金红,耿朝辉,段江燕,等.MTT比色法在贴壁细胞药物敏感型测定中的应用[J].南开大学学报(自然科学版),1996,29(4)：109
[40]Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration:enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation,2002,106 (24):3009-3017.
[41]Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment inpatients with acute myocardia infaretion(TOPCARE-AMI):mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation,2003,108 (18):2212-2218.
[42]Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002,418 (6893):41-49.
[43]Le Blanc K, Rasmusson L, Sundberg B, et al. Treatment of severe acute Graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet,2004,363 (9419):1439-1441.
[44]Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells modifled with akt prevent remodeling and restore performance of infarcted hearts[J]. Stem Cells,2004,22:377-384.
[45]Zhang Y, Chu Y, Shen W, et al. Effect of 5-azacyt idine induct ion duration on differentiation of human first-trimester fetal mesenchymal stem cells towards cardiomyocyte-like cells [J]. Interact Cardiovasc Thorac Surg,2009,9 (6):943-946.
[46]Huang JL,Yang SX. Safety of umbilical cord blood-derived mesenchymal stem cells (BMSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by BMSCs[J]. Saudi Med J,2009,30 (9):1144-1149.
[47]Rameshwar P, Qiu H, Vatner SF. Stem cells in cardiac repair in an inflammatory microenvironment[J].Minerva Cardioangiol, 2010,58(1):127-146.
[48]郑景辉,李勇华,王丽萍,等.心血瘀阻证微环境对骨髓间充质干细胞向心肌样细胞分化的影响[J].湖南中医药大学学报,2010,30(9)：38-42.
[49]Hamidouche Z, Hay E, Vaudin P,et al. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression[J]. FASEB J,2008,22:3813-3822.
[50]Bocelli-Tyndall C, Bracci L, Schaeren S, et al. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro prol iferat ion of lymphocytes stimulated by interleukins 2,7 and 15 [J]. Ann Rheum Dis,2009,68:1352-1359.
[51]Matsushita K, Wu Y, Okamoto Y, et al. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes[J]. Hypertension,2006,48:1095-1102
[52]Aurich I, Mueller LP, Aurich H, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers[J]. Gut,2007,56:405-415.
[53]Martinez C, Hofmann TJ,Marino R, et al. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of BMSCs [J]. Blood,2007,109:4245-4248.
[54]Hakuno D, Fukuda K. Bone marrow-derived regenerated cardio-myocytes (CMGcells) express functional adrenergic and muscarinic receptor [J]. Circulation,2002,105 (3):380-386.
[55]Makino S, Fukuda k, Miyoshi S. et al. Cardiomyocytes can be generated from marrow stromal cells invitro[J].J Clin Invest, 1999,103 (5):697-705.
[56]Wakitani S,Saito T, Caplan AI.Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve,1995,18(12):1417-1426.
[57]Tomita S, Li RK, Weisel RD, et al. Autologous transplant ion of bone marrow cells improves damaged heart function. Circulation. 1999; 100 (Suppl Ⅱ):247-256.
[58]付国伟,赵文增,文冰,等.不同浓度的5-氮胞苷对人骨髓间充质干细胞向心肌细胞分化的影响[J].心脏杂志,2008,20(5)：545-548.
[59]方天翔,闵军,邓小耿,等.肝细胞生长因子诱导骨髓间充质肝细胞分化为心肌细胞[J].中国病理生理杂志,2004,20(7)：1167-1170.
[60]Tomita S, Nakatani T, Fukuhara S, et al. Bone marrow stromal cells contract synchronously with cardiomyocytes in acoculture system[J].J Thorac Cardiovasc Surg,2002,50(8):321-324.
[61]常静,雷寒,陈建斌,等.大鼠心肌细胞诱导人骨髓问充质干细胞向心肌样细胞分化的研究[J].重庆医科大学学报,2007,32(9)：907-910.
[62]Ball SQ, Shuttleworth AC,Kielty CM, et al. Direct cell contact influences bone marrow mesencymal stem cell fate[J].Int J Biochem Cell Bio,2004,36 (4):714-727.
[63]Rangappa S, Entwistle JW, Wechsler AS, et al. Cardiomyocyte mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype[J]. J Thorac Cardiovasc Surg, 2003,126(1):124-132.
[64]Xu M, Wani M,Dai YS, et al. Differentiation of bone marrow stromal cells into thecardiac phenotype requires intercellular communication with myocytes[J]. Circulation,2004,110 (17):2658-2665.
[65]赵春华.干细胞原理、技术与临床[M].北京化学工业出版社,2006：625-627.
[66]Hakuno DH, Fukuda K, Makino S, et al. Bone marrow-derived regenerated Cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors[J]. Circulation,2002,105 (3):380-386.
[67]Orlic D,Kajstura J,Chimenti S, et al. Bone marrow cells regenerate infracted myocardium[J]. Natrue,2001,410:701-705.
[68]李艳芬,孙兰军,赵英强,等.复方丹参滴丸干预骨髓间充质干细胞移植后心肌再生的实验研究[J].中国中医药现代远程教育,2009,9：81-83.
[69]陆长青,冉黎,张全波,等.丹参诱导骨髓间充质干细胞向神经元样细胞分化及相关基因的表达[J].中国组织工程研究与临床康复,2008,12(47)：9363-9366.
[70]Brewer AC, Alexandrovieh A,Mjaatvedt CH.GATA factors lie upstream of Nkx2.5 in the transcriptional regulatory cascade that effects cardiogenesis[J]. Stem Cells Dev2005,14 (4):425-439.
[71]Frederic Charron, Pierre Paradis, Odile Bronehain, et al. Cooperative Interaction between GATA-4 and GATA-6 Reuglates Myoeardial Gene Expression[J]. Molecular and Cellular Biology, 1999,19(6):4355-4365.
[72]C GrePin,G Nemerand M Nemer. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor[J]. Development,2003,124(12):2387-2395.
[73]Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs,2001,25:187-193.
[74]Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe post infarction left ventricular dysfunetion. J Am Coll Cardiol.2003,41 (7):1078-1083.
[75]Philippe Menasche. Myoblast-Based.Cell Transplantation[J]. Heart Failure Reviews,2003,8(3):221-227.
[76]Pittenger MF,Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J].Science,1999,284(2): 143-147.
[77]Paul D,Samuel SM,Maulik N,Mesenchymal stem cells:present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration[J]. Antioxid Redox Signal,2009; 11(8):1841-1855.
[78]Strauer BE, Brehm M, Zeus T, et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans[J]. Circulation,2002,106 (15):1913- 1918.
[79]Tomita S,Mickle DA,Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation[J]. J Thorac Cardiovasc Surg,2002,123(6):1132-1140.
[80]Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells [J].J Clin Invest 2001; 107 (11):1395-1402.
[81]Saito T, Kuang JQ, Lin CH, et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction[J]. J Thorac Cardiovasc Surg,2003,126 (1):114-122.
[82]袁肇凯.中医诊断试验方法学(第2版)[M].北京：科学技术出版社,2006：257-258.
[83]陈世宏,叶耘,尚正录,等。不同治法对大鼠心肌缺血模型中医证型的反证研究[J].上海中医药大学学报,2005,19(4)36-38
[84]Li RK, Mickle DA, Weisel RD, et al. Opt imal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury[J]. Am Thorac Surg,2001,72 (6):1957-1963.
[85]Hughes GC, Post MJ, Simons M, et al. Translational physiology: porcine models of human coronary artery disease:implications for preclinical trials of therapeutic angigenesis[J]. Appl Physiol,2003,94:1689-1701.
[86]Pagani FD, Simonian HD, Zawadzka A, et al. Autologous Skeletal Myoblasts Transplanted to ischemia damaged myocardium in Humans[J]. Journal of the American Col lege of Cardiology,2003, (41):879-888.
[87]黄国倩,刘虹,舒先红,等.超声心动图评价粒细胞集落刺激因子动员自身骨髓干细胞对心肌梗死后左心室重构及心功能的影响[J].中华超声影像学杂志,2004,13(11)：848-852.
[88]和岚,蒋文跃,毛腾敏.注射肾上腺素模拟“气滞”复制急、慢性血瘀模型初探[J].中国中西医结合杂志,2004,24(3)：244-246.
[89]王佳.吉林大学硕士论文：大鼠：“血瘀证”下急性心肌梗死模型的建立和评价,2007.
[90]Zhang H, Xu C, Liang L, et al. Part icipat ion of bone marrow derived mesenchymal stem cells in corneal epithelial wound healing[J]. Invest Ophthalmol Vis Sci,2008,49:6071.
[91]李玉玲,唐俊明,潘国栋,等.DAPI标记的骨髓间充质干细胞体内外示踪实验研究[J].郧阳医学院学报,2005,24(5)：57-260.
[92]刘伯轩,刘师伟,王建华,等.DAPI标记的骨髓间充质干细胞体内外示踪实验研究[J].中国药物与临床,2009,9(8)：703-705.
[93]黄新苗,秦永文.骨髓干细胞自体移植治疗缺血性心脏病的理论和实践.中国临床康复,2003；7(30)：4132-4134.
[94]Ren G,Michael LH,et al. Morphological characteristics of the microvasculature in heal ing myocardial infarcts[J].J Histochem Cytochem,2002; 51:71-79.
[95]曹丰,贾国良,牛丽丽,等.移植时机对骨髓间充质干细胞修复梗死心肌的影响[J].第四军医大学学报,2005,26(1)：24.
[96]Xu HX, Li GS, Jiang H, et al. Implantation of BM cells transfected with phVEGF165 enhances functional improvement of the infarcted heart[J]. Cytotherapy,2004,6 (3):204-211.
[97]Israel MB, Pierre C,Juck B, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium:Feasibi lity cell migration and body distributions. Circulation,2003,108(7):863-868.
[98]Per in EC, Dohmann HF, Borojevic R, et al. Transendocardial autologous bone marrow cell transplantation for severe chronic ischemic heart failure. Circulation,2003,107 (18):2294-2302.
[99]Hamano K, Nishida M, Hirata K, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease:clinical trial and preliminary results. Jpn Circ J.2001,65(9):845-847.
[100]廖菁,黄政德,葛金文,等.JWDSY对大鼠实验性心肌缺血损伤的影响[J].湖南中医学院学报,2006,26(3)：6-8.
[101]黄政德,王庆高,刘东亮,等.JWDSY预处理对心肌细胞内钙超载的延迟保护作用[J].湖南中医药大学学报,2007,27(2)：37-39.
[102]黄政德,李鑫辉,谢雪姣,等.活血化瘀药对血瘀型心肌缺血再灌注损伤家兔内源性活性因子及炎症因子的影响[J].中华中医药学刊,2007,25(7)：1319-1321.
[103]王庆高,黄政德,肖健,等.JWDSY预处理对乳鼠缺氧/复氧心肌细胞的延迟保护作用及对蛋白激酶C的影响[J].中西医结合心脑血管病杂志,2007,5(10)：953-955.
[104]李鑫辉,黄政德,司友琴,等.益气活血法对缺血再灌注损伤血瘀型兔心肌细胞间黏附分子-1表达的影响[J].湖南中医药大学学报,2007,27(6)：30-33.
[105]黄政德,李鑫辉,张少泉,等.益气活血法对血瘀型兔缺血再灌注心肌细胞核因子κB蛋白表达影响[J].中华中医药学刊,2008,26(8)：1629-1631.
[106]廖菁,黄政德,胡华,等.JWDSY对大鼠实验性心肌缺血损伤的抗凝血作用研究[J].中国中医药信息杂志,2009,16(1)：44-45,98.
[107]李鑫辉,黄政德,喻嵘,等.JWDSY对血瘀型家兔缺血再灌注损伤心肌细胞凋亡的影响[J].湖南中医药大学学报,2009,29(4)：21-23.29.
[108]李维革,韩宁.从络病理论探讨中风病微观病机[J].辽宁中医药大学学报,2006,8(6)：18.
[109]张文海,李秀兰,张杨,等.中药生肌液对兔骨髓间充质干细胞增殖活性的影响[J].中国中西医结合外科杂志,2007,13(2)：146-149.
[110]李勇华,袁肇凯,郑景辉,等.养心通脉有效部位方与急性心肌梗死大鼠骨髓间充质干细胞的动员及定向归巢[J].中国组织工程研究与临床康复,2010,14(23)：4285-4289.
[1]葛均波,张少衡.干细胞能再生梗死心肌吗[J].中华医学杂志,2005；85(36)：2530-2531.
[2]Beltrami AP, Mrbanek K, Kajstura J,et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med,2001,344(23):1750-1757.
[3]Quaini F,Mrbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med.2002,346 (1):5-15.
[4]Li RK, Yau TM, Sakai T, et al. Cell therapy to repair broken heart. Can J Cardiol,1998,14 (5):735-744.
[5]徐凯.成体干细胞移植在冠心病治疗中的引用进展[J].国外医学临床生物化学与检验学分册,2005,VOl,26,NO.5.
[6]Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research,2004, 95(1):9-20.
[7]Friedenstein AJ, Deriglasova MF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol,1974;2(2):83-92.
[8]CoLter DC, CLass R, Digirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone mar row [J]. Proc Natl Acad Sci MSA,2000; 97(7): 3213-3218.
[9]裴雪涛主编.干细胞生物学[M].北京：科学出版社,2003：1-5.
[10]马力,刘大军,李德天,等.不同分离方法及培养条件对兔骨髓间充质干细胞生长增殖及生物学特性的影响[J].中国组织工程研究与临床康复,2008,12(38)：7401-7406.
[11]Tsai RY, Kittappa R, Me Kay RD. Plasticity, niches, and the use of stem cells[J].Dev Cell,2002,2 (10):707-712.
[12]Peister A,Mellad JA, Wang M, et al. Stable transfection of MSCs by electroporation. Gene Ther,2004,11 (2) 224-228.
[13]Jones E, Mcgonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford).2008; 47 (2):126-131.
[14]Liu Y, Song J,Liu X,et al. Growth and differentiation of rat bone marrow stromal cells:does 5-azacytidine trigger their cardiomyo-genie differentiation. Cardiovasc,2003,58 (2):460-468.
[15]Pittenger MF, Mackay AM, Beck SC, et al. Mul til ineage potential of adult human mesenchymal stem cells[J]. Science,1999,284 (2):143-147.
[16]Zhang Y, Chu Y, Shen W, et al. Effect of 5-azacyt idine induct ion duration on differentiation of human first-trimester fetal mesenchymal stem cells towards cardiomyocyte-like cells[J]. Interact Cardiovasc Thorac Surg,2009,9 (6):943-946.
[17]Huang JL, Yang SX. Safety of umbilical cord blood-derived mesenchymal stem cells (BMSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by BMSCs[J]. Saudi Med J,2009,30 (9):1144-1149.
[18]Rameshwar P,Qiu H, Vatner SF. Stem cells in cardiac repair in an inflammatory microenvironment[J]. Minerva Cardioangiol, 2010,58(1):127-146.
[19]郑景辉,李勇华,王丽萍,等.心血瘀阻证微环境对骨髓间充质干细胞向心肌样细胞分化的影响[J].湖南中医药大学学报,2010,30(9)：38-42.
[20]Xu W, Zhang X, Qian H, et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro[J].Exp Biol Med,2004,229:623-631.
[21]常静,雷寒,陈建斌,等.大鼠心肌细胞诱导人骨髓问充质干细胞向心肌样细胞分化的研究[J].重庆医科大学学报,2007,32(9)：907-910.
[22]Tomita S,Nakatani T, Fukuhara S, et al. Bone marrow stromal cells contract synchronously with cardiomyocytes in acoculture system[J].J Thorac Cardiovasc Surg,2002,50 (8): 321-324.
[23]毛泽斌,张宗玉,童坦君.DNA去甲基化对细胞衰老的影响.中国生物化学与分子生物学报,1997,13(3)：318-321.
[24]Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascuar izat ion of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis,reduces remodeling and improve cardialc function[J]. Nat Med,2001; 7 (4):430-436.
[25]Jay G, Shake MD, Gruber MD, et al. Mesenchymalstem cells implanation in a swine myocardial infarct model:engraftment and functional effects[J]. Am Thorac Surg Jun,2002,73:191-226.
[26]Shake JG,Gruber PJ,Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects[J]. Am Thorac Surg Jun, 2002,73(6):1919-1925.
[27]曾知恒,黄晓静,林葆菁,等.自体骨髓干细胞移植治疗急性心肌梗死的实验研究[J].广西医科大学学报,2008,25(4)：511-513.
[28]Skalickd H JR,Horak J. Myocardial infarction,left ventricl remodeling and cellular therapy[J]. Vnitr Lek,2009,55 (1):37-44.
[29]Tendem M, Wojakowski W. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction:results of randomized, multicentre Myocardial Regeneration by Intraeomnary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT)Trial[J].Eur Heart J,2009, 30(11):1313-1321.
[30]Hagikura K,Fukuda N,Yokoyama SI. Low invasive angiogenic therapy formyocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene[J].Int J Cardiol,2009, Jan:22.
[31]Brazelton TR, Rossi FM, Keshet GL, et al. From marrow to rain:Expression of neuronal phenotype in adult mice[J]. Science,2000,209:1775-1779.
[32]Wright DE, Amy JW, Anjali PG, et al. Physiological migration of hematopoietic stem and progenitor cells[J].Science,2001,294: 1933-1936.
[33]J. F Bentzon, K S tender up, FD Hansen, et al. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene[J]. Biochem Biophys Res Commun,2005,330(3):633-640.
[34]武峰,王海昌,王跃民,等.动员自体骨髓干细胞对急性心肌梗死大鼠心功能的影响[J].心脏杂志,2005,17(4)：326-329.
[35]余晓燕,王春梅,姜涛,等.干细胞因子在正常及梗死心肌中的表达[J].中国介入心脏病学杂志,2004,12(5)：297-300.
[36]王立新,王奇,石海燕,等.骨髓干细胞动员治疗急性心肌梗死[J].中国比较医学杂志,2007,17(5)：249-252.
[37]冼绍祥,杨忠奇,汪朝晖,等.黄芪甲苷体外诱导骨髓间充质干细胞分化为心月几样细胞的实验研究[J].广州中医药大学学报,2007,24(1)：37-40.
[38]范英昌,华生瑜,姚雅娟.丹酚酸B诱导体外培养大鼠骨髓基质细胞向心肌样细胞分化的研究[J].天津中医学院学报,2005,24(1)：10-12.
[39]宋清,张晓文,卢新政,等.参三七皂苷Rgl预适应对5-氮胞苷诱导大鼠骨髓间充质干细胞向心肌细胞转化的干预[J].中国组织工程研究与临床康复,2007,11(24)：4693-469.
[40]曾意荣,樊粤光,刘红,等.补肾活血中药对大鼠骨髓间充质干细胞体外增殖的影响[J].中国组织工程研究与临床康复,2008,12(8)：1545-1547.
[41]李连达,张荣利,刘成源,等.双龙方与自体骨髓单个核细胞经心导管移植对中国小型猪心肌梗死的影响[J].中国新药杂志,2003,12(12)：999-1003.
[42]倪玉霞,刘小青,李贻奎,等.骨髓间充质干细胞移植联合冠心Ⅱ号对大鼠急性心肌梗死心功能和血管新生的影响.中国组织工程与临床康复,2008,12(47)：9201-9209.
[43]李广斌,苏金玲,姜希娟,等.中药心复康在大鼠急性心肌梗塞后对移植骨髓间充质干细胞的保护作用[J].时珍国医国药,2009,20(12)：3043-3045.
[44]李广斌,苏金玲,姜希娟,等.中药心复康联合骨髓间充质干细胞移植对大鼠急性心肌梗死后心功能的影响[J].天津中医药大学学报,2009,28(2)：78-80.
[45]钟鸣,苏海.心肌损伤时复方丹参滴丸的骨髓动员作用[J].浙江中西医结合杂志,2008,18(9)：529-531.
[2]Quaini F, Mrbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med,2002,346 (1):5-15.
[3]Lev S,Kehat L,GePstein L.Differentiation pathways in human embryonic stem cell derived cardiomyocytes [J]. Ann NY Aead Sci,2005,1047(1):50-65.
[4]Planat-Benard V,Menard C,Andre M,et al. Spontaneous cardio-myocyte differentiation from adipose tissue stroma cells.Cir Res,2004,943:223-229.
[5]张近宝,顾春虎,刘维水,等.犬骨髓间充质干细胞可诱导分化为组织工程瓣间质种子细胞[J].心脏杂志,2006；18(5)：489-491、495.
[6]Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002,418:41-49.
[7]Yoon YS,Wecker A, Heyd L, et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest,2005, 115:326-338.
[8]Valiunas V, Doronin S, Valiuniene L, et a 1. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J Physiol,2004,555:617-626.
[9]党懿,齐晓勇,孟存良,等.骨髓间充质干细胞体外诱导培养后的电生理特性.[J]中国组织工程研究与临床康复,2009；13(27)：5261-5264.
[10]霍艳明,郭维琴,戴雁彦,等.益气活血化瘀法在急性心肌梗塞中的应用[J].北京中医药大学学报,1999,22(2)：46-47.
[11]周小青,王大安,肖雅,等.活血化瘀类方抗急性心肌缺血的实验研究.中西医结合心脑血管病杂志,2003,1(4)：187-188.
[12]杨祖福,胡婉英,秦志强,等.双龙丸对实验性大鼠心肌梗死血管新生的影响与分子学机制[J].中国康复理论与实践,2003,9(5)：293-295.
[13]裴雪涛主编.干细胞生物学[M],北京：科学出版社,2003：4-7.
[14]Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe post infarction left ventricular dysfunction[J].J Am Cell Cardiol,2003,41 (7): 1078-1083.
[15]Colter DC, Class R, Digirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow[J]. Proc Natl Acad Sci MSA,2000,97 (7):3213-3218
[16]Muraglia A,Cancedda R,Quarto R.Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci,2000,113:1161-1166.
[17]马力,刘大军,李德天,等.不同分离方法及培养条件对兔骨髓间充质干细胞生长增殖及生物学特性的影响[J].中国组织工程研究与临床康复,2008,12(38)：7401-7406.
[18]中华人民共和国科学技术部.关于善待实验动物的指导性意见2006-09-30.
[19]Friedenstein AJ,Petrakova KV, Kurolesova AI,et al. Hetero-topic of bone marrow:Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation,1968, 6(2):230-247.
[20]Friedenstein AJ. Precursor cells of mechanocytes. Int Revctol, 1976,47:327-355.
[21]Krause DS. Bone marrow derived cells and stem cells in lung repair[J]. Proc Am Thorac Soc,2008,5:323-327.
[22]Balsam LB, Wagers AJ, Christensen JL, et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature,2004,428 (6983):668—673.
[23]Murry CE, Soonpaa MH, Reineeke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature,2004,28 (6983):664-668.
[24]Keiichi F, Shinsuke Y. Stem cells as a source of regenerative cardiomyocytes[J]. Circ Res,2006,4:1002-1013.
[25]Tan SCW, Pan WX, Ma G, et al. Viscoelastic behavior of human mesenchymal stem cells[J]. BMC Cell Biol,2008,9:40-47.
[26]Summer R,Fine A. Mesenchymal progenitor cell research: limitations and recommendations[J]. Proc Am Thorac Soc,2008, 5:707-710.
[27]Zhang S, Ge J, Sun A, et al. Comparison of various kinds of bone marrow stem cells for the repair of infarcted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem,2006,99 (4): 1132-1147.
[28]Morito T,Munetal T, Hara K, et al. Synovial fluid-derived mesenchymal stem cells increase after intra-articular ligament injury in humans[J]. Rheumatology,2008,47:1137-1143.
[29]卢新政,张晓文,黄峻,等.大鼠骨髓间充质干细胞培养方法的改良[J].中国心血管杂志,2004,9(1)：48-51.
[30]Conge t PA, Minguell JJ. Pheno typical and functional properties of human bone marrow mesenchymal progenitor cells[J],J Cell Physiol,1999,181(1):63-73.
[31]Secco M, Zucconi E, Vieira NM, et al. Mul tipotent stem cells from umbilical cord:cord is richer than blood!Stem Cells,2008, 26(1):146-150.
[32]Peister A,Mellad JA, Wang M, et al. Stable transfection of MSCs by electroporation. Gene Ther,2004,11 (2) 224-228.
[33]Jones E, Mcgonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford),2008,47 (2):126-131.
[34]Liu Y, Song J,Liu X, et al. Growth and differentiation of rat bone marrow stromal cells:does 5-azacytidine trigger their cardiomyo-genie differentiation. Cardiovasc,2003,58 (2):460-468.
[35]王跃春,张洹.人胎骨髓MSCs的分离鉴定及其向肝细胞样的分化[J].中国病理生理杂志,2007,23(11)：2205-2209.
[36]戴文达,方涛林,李熙雷,等.人骨髓间充质干细胞的分离培养、多向分化与鉴定[J].复旦学报,医学版,2008,35(3)：448-452.
[37]Yoshimura H, Muneta T, Nimura A, et al. Comparison of rat mesenchymal stem cells derived from bone marrow. synovium, periosteum, adipose tissue and muscle[J].Cell Tissue Res, 2007,327 (3):449-462.
[38]司徒镇强,吴正军.细胞培养[M].西安：世界图书出版社,2007：250.
[39]张金红,耿朝辉,段江燕,等.MTT比色法在贴壁细胞药物敏感型测定中的应用[J].南开大学学报(自然科学版),1996,29(4)：109
[40]Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration:enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation,2002,106 (24):3009-3017.
[41]Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment inpatients with acute myocardia infaretion(TOPCARE-AMI):mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation,2003,108 (18):2212-2218.
[42]Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002,418 (6893):41-49.
[43]Le Blanc K, Rasmusson L, Sundberg B, et al. Treatment of severe acute Graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet,2004,363 (9419):1439-1441.
[44]Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells modifled with akt prevent remodeling and restore performance of infarcted hearts[J]. Stem Cells,2004,22:377-384.
[45]Zhang Y, Chu Y, Shen W, et al. Effect of 5-azacyt idine induct ion duration on differentiation of human first-trimester fetal mesenchymal stem cells towards cardiomyocyte-like cells [J]. Interact Cardiovasc Thorac Surg,2009,9 (6):943-946.
[46]Huang JL,Yang SX. Safety of umbilical cord blood-derived mesenchymal stem cells (BMSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by BMSCs[J]. Saudi Med J,2009,30 (9):1144-1149.
[47]Rameshwar P, Qiu H, Vatner SF. Stem cells in cardiac repair in an inflammatory microenvironment[J].Minerva Cardioangiol, 2010,58(1):127-146.
[48]郑景辉,李勇华,王丽萍,等.心血瘀阻证微环境对骨髓间充质干细胞向心肌样细胞分化的影响[J].湖南中医药大学学报,2010,30(9)：38-42.
[49]Hamidouche Z, Hay E, Vaudin P,et al. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression[J]. FASEB J,2008,22:3813-3822.
[50]Bocelli-Tyndall C, Bracci L, Schaeren S, et al. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro prol iferat ion of lymphocytes stimulated by interleukins 2,7 and 15 [J]. Ann Rheum Dis,2009,68:1352-1359.
[51]Matsushita K, Wu Y, Okamoto Y, et al. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes[J]. Hypertension,2006,48:1095-1102
[52]Aurich I, Mueller LP, Aurich H, et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers[J]. Gut,2007,56:405-415.
[53]Martinez C, Hofmann TJ,Marino R, et al. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of BMSCs [J]. Blood,2007,109:4245-4248.
[54]Hakuno D, Fukuda K. Bone marrow-derived regenerated cardio-myocytes (CMGcells) express functional adrenergic and muscarinic receptor [J]. Circulation,2002,105 (3):380-386.
[55]Makino S, Fukuda k, Miyoshi S. et al. Cardiomyocytes can be generated from marrow stromal cells invitro[J].J Clin Invest, 1999,103 (5):697-705.
[56]Wakitani S,Saito T, Caplan AI.Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve,1995,18(12):1417-1426.
[57]Tomita S, Li RK, Weisel RD, et al. Autologous transplant ion of bone marrow cells improves damaged heart function. Circulation. 1999; 100 (Suppl Ⅱ):247-256.
[58]付国伟,赵文增,文冰,等.不同浓度的5-氮胞苷对人骨髓间充质干细胞向心肌细胞分化的影响[J].心脏杂志,2008,20(5)：545-548.
[59]方天翔,闵军,邓小耿,等.肝细胞生长因子诱导骨髓间充质肝细胞分化为心肌细胞[J].中国病理生理杂志,2004,20(7)：1167-1170.
[60]Tomita S, Nakatani T, Fukuhara S, et al. Bone marrow stromal cells contract synchronously with cardiomyocytes in acoculture system[J].J Thorac Cardiovasc Surg,2002,50(8):321-324.
[61]常静,雷寒,陈建斌,等.大鼠心肌细胞诱导人骨髓问充质干细胞向心肌样细胞分化的研究[J].重庆医科大学学报,2007,32(9)：907-910.
[62]Ball SQ, Shuttleworth AC,Kielty CM, et al. Direct cell contact influences bone marrow mesencymal stem cell fate[J].Int J Biochem Cell Bio,2004,36 (4):714-727.
[63]Rangappa S, Entwistle JW, Wechsler AS, et al. Cardiomyocyte mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype[J]. J Thorac Cardiovasc Surg, 2003,126(1):124-132.
[64]Xu M, Wani M,Dai YS, et al. Differentiation of bone marrow stromal cells into thecardiac phenotype requires intercellular communication with myocytes[J]. Circulation,2004,110 (17):2658-2665.
[65]赵春华.干细胞原理、技术与临床[M].北京化学工业出版社,2006：625-627.
[66]Hakuno DH, Fukuda K, Makino S, et al. Bone marrow-derived regenerated Cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors[J]. Circulation,2002,105 (3):380-386.
[67]Orlic D,Kajstura J,Chimenti S, et al. Bone marrow cells regenerate infracted myocardium[J]. Natrue,2001,410:701-705.
[68]李艳芬,孙兰军,赵英强,等.复方丹参滴丸干预骨髓间充质干细胞移植后心肌再生的实验研究[J].中国中医药现代远程教育,2009,9：81-83.
[69]陆长青,冉黎,张全波,等.丹参诱导骨髓间充质干细胞向神经元样细胞分化及相关基因的表达[J].中国组织工程研究与临床康复,2008,12(47)：9363-9366.
[70]Brewer AC, Alexandrovieh A,Mjaatvedt CH.GATA factors lie upstream of Nkx2.5 in the transcriptional regulatory cascade that effects cardiogenesis[J]. Stem Cells Dev2005,14 (4):425-439.
[71]Frederic Charron, Pierre Paradis, Odile Bronehain, et al. Cooperative Interaction between GATA-4 and GATA-6 Reuglates Myoeardial Gene Expression[J]. Molecular and Cellular Biology, 1999,19(6):4355-4365.
[72]C GrePin,G Nemerand M Nemer. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor[J]. Development,2003,124(12):2387-2395.
[73]Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs,2001,25:187-193.
[74]Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe post infarction left ventricular dysfunetion. J Am Coll Cardiol.2003,41 (7):1078-1083.
[75]Philippe Menasche. Myoblast-Based.Cell Transplantation[J]. Heart Failure Reviews,2003,8(3):221-227.
[76]Pittenger MF,Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells[J].Science,1999,284(2): 143-147.
[77]Paul D,Samuel SM,Maulik N,Mesenchymal stem cells:present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration[J]. Antioxid Redox Signal,2009; 11(8):1841-1855.
[78]Strauer BE, Brehm M, Zeus T, et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans[J]. Circulation,2002,106 (15):1913- 1918.
[79]Tomita S,Mickle DA,Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation[J]. J Thorac Cardiovasc Surg,2002,123(6):1132-1140.
[80]Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells [J].J Clin Invest 2001; 107 (11):1395-1402.
[81]Saito T, Kuang JQ, Lin CH, et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction[J]. J Thorac Cardiovasc Surg,2003,126 (1):114-122.
[82]袁肇凯.中医诊断试验方法学(第2版)[M].北京：科学技术出版社,2006：257-258.
[83]陈世宏,叶耘,尚正录,等。不同治法对大鼠心肌缺血模型中医证型的反证研究[J].上海中医药大学学报,2005,19(4)36-38
[84]Li RK, Mickle DA, Weisel RD, et al. Opt imal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury[J]. Am Thorac Surg,2001,72 (6):1957-1963.
[85]Hughes GC, Post MJ, Simons M, et al. Translational physiology: porcine models of human coronary artery disease:implications for preclinical trials of therapeutic angigenesis[J]. Appl Physiol,2003,94:1689-1701.
[86]Pagani FD, Simonian HD, Zawadzka A, et al. Autologous Skeletal Myoblasts Transplanted to ischemia damaged myocardium in Humans[J]. Journal of the American Col lege of Cardiology,2003, (41):879-888.
[87]黄国倩,刘虹,舒先红,等.超声心动图评价粒细胞集落刺激因子动员自身骨髓干细胞对心肌梗死后左心室重构及心功能的影响[J].中华超声影像学杂志,2004,13(11)：848-852.
[88]和岚,蒋文跃,毛腾敏.注射肾上腺素模拟“气滞”复制急、慢性血瘀模型初探[J].中国中西医结合杂志,2004,24(3)：244-246.
[89]王佳.吉林大学硕士论文：大鼠：“血瘀证”下急性心肌梗死模型的建立和评价,2007.
[90]Zhang H, Xu C, Liang L, et al. Part icipat ion of bone marrow derived mesenchymal stem cells in corneal epithelial wound healing[J]. Invest Ophthalmol Vis Sci,2008,49:6071.
[91]李玉玲,唐俊明,潘国栋,等.DAPI标记的骨髓间充质干细胞体内外示踪实验研究[J].郧阳医学院学报,2005,24(5)：57-260.
[92]刘伯轩,刘师伟,王建华,等.DAPI标记的骨髓间充质干细胞体内外示踪实验研究[J].中国药物与临床,2009,9(8)：703-705.
[93]黄新苗,秦永文.骨髓干细胞自体移植治疗缺血性心脏病的理论和实践.中国临床康复,2003；7(30)：4132-4134.
[94]Ren G,Michael LH,et al. Morphological characteristics of the microvasculature in heal ing myocardial infarcts[J].J Histochem Cytochem,2002; 51:71-79.
[95]曹丰,贾国良,牛丽丽,等.移植时机对骨髓间充质干细胞修复梗死心肌的影响[J].第四军医大学学报,2005,26(1)：24.
[96]Xu HX, Li GS, Jiang H, et al. Implantation of BM cells transfected with phVEGF165 enhances functional improvement of the infarcted heart[J]. Cytotherapy,2004,6 (3):204-211.
[97]Israel MB, Pierre C,Juck B, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium:Feasibi lity cell migration and body distributions. Circulation,2003,108(7):863-868.
[98]Per in EC, Dohmann HF, Borojevic R, et al. Transendocardial autologous bone marrow cell transplantation for severe chronic ischemic heart failure. Circulation,2003,107 (18):2294-2302.
[99]Hamano K, Nishida M, Hirata K, et al. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease:clinical trial and preliminary results. Jpn Circ J.2001,65(9):845-847.
[100]廖菁,黄政德,葛金文,等.JWDSY对大鼠实验性心肌缺血损伤的影响[J].湖南中医学院学报,2006,26(3)：6-8.
[101]黄政德,王庆高,刘东亮,等.JWDSY预处理对心肌细胞内钙超载的延迟保护作用[J].湖南中医药大学学报,2007,27(2)：37-39.
[102]黄政德,李鑫辉,谢雪姣,等.活血化瘀药对血瘀型心肌缺血再灌注损伤家兔内源性活性因子及炎症因子的影响[J].中华中医药学刊,2007,25(7)：1319-1321.
[103]王庆高,黄政德,肖健,等.JWDSY预处理对乳鼠缺氧/复氧心肌细胞的延迟保护作用及对蛋白激酶C的影响[J].中西医结合心脑血管病杂志,2007,5(10)：953-955.
[104]李鑫辉,黄政德,司友琴,等.益气活血法对缺血再灌注损伤血瘀型兔心肌细胞间黏附分子-1表达的影响[J].湖南中医药大学学报,2007,27(6)：30-33.
[105]黄政德,李鑫辉,张少泉,等.益气活血法对血瘀型兔缺血再灌注心肌细胞核因子κB蛋白表达影响[J].中华中医药学刊,2008,26(8)：1629-1631.
[106]廖菁,黄政德,胡华,等.JWDSY对大鼠实验性心肌缺血损伤的抗凝血作用研究[J].中国中医药信息杂志,2009,16(1)：44-45,98.
[107]李鑫辉,黄政德,喻嵘,等.JWDSY对血瘀型家兔缺血再灌注损伤心肌细胞凋亡的影响[J].湖南中医药大学学报,2009,29(4)：21-23.29.
[108]李维革,韩宁.从络病理论探讨中风病微观病机[J].辽宁中医药大学学报,2006,8(6)：18.
[109]张文海,李秀兰,张杨,等.中药生肌液对兔骨髓间充质干细胞增殖活性的影响[J].中国中西医结合外科杂志,2007,13(2)：146-149.
[110]李勇华,袁肇凯,郑景辉,等.养心通脉有效部位方与急性心肌梗死大鼠骨髓间充质干细胞的动员及定向归巢[J].中国组织工程研究与临床康复,2010,14(23)：4285-4289.
[1]葛均波,张少衡.干细胞能再生梗死心肌吗[J].中华医学杂志,2005；85(36)：2530-2531.
[2]Beltrami AP, Mrbanek K, Kajstura J,et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med,2001,344(23):1750-1757.
[3]Quaini F,Mrbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med.2002,346 (1):5-15.
[4]Li RK, Yau TM, Sakai T, et al. Cell therapy to repair broken heart. Can J Cardiol,1998,14 (5):735-744.
[5]徐凯.成体干细胞移植在冠心病治疗中的引用进展[J].国外医学临床生物化学与检验学分册,2005,VOl,26,NO.5.
[6]Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research,2004, 95(1):9-20.
[7]Friedenstein AJ, Deriglasova MF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol,1974;2(2):83-92.
[8]CoLter DC, CLass R, Digirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone mar row [J]. Proc Natl Acad Sci MSA,2000; 97(7): 3213-3218.
[9]裴雪涛主编.干细胞生物学[M].北京：科学出版社,2003：1-5.
[10]马力,刘大军,李德天,等.不同分离方法及培养条件对兔骨髓间充质干细胞生长增殖及生物学特性的影响[J].中国组织工程研究与临床康复,2008,12(38)：7401-7406.
[11]Tsai RY, Kittappa R, Me Kay RD. Plasticity, niches, and the use of stem cells[J].Dev Cell,2002,2 (10):707-712.
[12]Peister A,Mellad JA, Wang M, et al. Stable transfection of MSCs by electroporation. Gene Ther,2004,11 (2) 224-228.
[13]Jones E, Mcgonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford).2008; 47 (2):126-131.
[14]Liu Y, Song J,Liu X,et al. Growth and differentiation of rat bone marrow stromal cells:does 5-azacytidine trigger their cardiomyo-genie differentiation. Cardiovasc,2003,58 (2):460-468.
[15]Pittenger MF, Mackay AM, Beck SC, et al. Mul til ineage potential of adult human mesenchymal stem cells[J]. Science,1999,284 (2):143-147.
[16]Zhang Y, Chu Y, Shen W, et al. Effect of 5-azacyt idine induct ion duration on differentiation of human first-trimester fetal mesenchymal stem cells towards cardiomyocyte-like cells[J]. Interact Cardiovasc Thorac Surg,2009,9 (6):943-946.
[17]Huang JL, Yang SX. Safety of umbilical cord blood-derived mesenchymal stem cells (BMSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by BMSCs[J]. Saudi Med J,2009,30 (9):1144-1149.
[18]Rameshwar P,Qiu H, Vatner SF. Stem cells in cardiac repair in an inflammatory microenvironment[J]. Minerva Cardioangiol, 2010,58(1):127-146.
[19]郑景辉,李勇华,王丽萍,等.心血瘀阻证微环境对骨髓间充质干细胞向心肌样细胞分化的影响[J].湖南中医药大学学报,2010,30(9)：38-42.
[20]Xu W, Zhang X, Qian H, et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro[J].Exp Biol Med,2004,229:623-631.
[21]常静,雷寒,陈建斌,等.大鼠心肌细胞诱导人骨髓问充质干细胞向心肌样细胞分化的研究[J].重庆医科大学学报,2007,32(9)：907-910.
[22]Tomita S,Nakatani T, Fukuhara S, et al. Bone marrow stromal cells contract synchronously with cardiomyocytes in acoculture system[J].J Thorac Cardiovasc Surg,2002,50 (8): 321-324.
[23]毛泽斌,张宗玉,童坦君.DNA去甲基化对细胞衰老的影响.中国生物化学与分子生物学报,1997,13(3)：318-321.
[24]Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascuar izat ion of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis,reduces remodeling and improve cardialc function[J]. Nat Med,2001; 7 (4):430-436.
[25]Jay G, Shake MD, Gruber MD, et al. Mesenchymalstem cells implanation in a swine myocardial infarct model:engraftment and functional effects[J]. Am Thorac Surg Jun,2002,73:191-226.
[26]Shake JG,Gruber PJ,Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects[J]. Am Thorac Surg Jun, 2002,73(6):1919-1925.
[27]曾知恒,黄晓静,林葆菁,等.自体骨髓干细胞移植治疗急性心肌梗死的实验研究[J].广西医科大学学报,2008,25(4)：511-513.
[28]Skalickd H JR,Horak J. Myocardial infarction,left ventricl remodeling and cellular therapy[J]. Vnitr Lek,2009,55 (1):37-44.
[29]Tendem M, Wojakowski W. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction:results of randomized, multicentre Myocardial Regeneration by Intraeomnary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT)Trial[J].Eur Heart J,2009, 30(11):1313-1321.
[30]Hagikura K,Fukuda N,Yokoyama SI. Low invasive angiogenic therapy formyocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene[J].Int J Cardiol,2009, Jan:22.
[31]Brazelton TR, Rossi FM, Keshet GL, et al. From marrow to rain:Expression of neuronal phenotype in adult mice[J]. Science,2000,209:1775-1779.
[32]Wright DE, Amy JW, Anjali PG, et al. Physiological migration of hematopoietic stem and progenitor cells[J].Science,2001,294: 1933-1936.
[33]J. F Bentzon, K S tender up, FD Hansen, et al. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene[J]. Biochem Biophys Res Commun,2005,330(3):633-640.
[34]武峰,王海昌,王跃民,等.动员自体骨髓干细胞对急性心肌梗死大鼠心功能的影响[J].心脏杂志,2005,17(4)：326-329.
[35]余晓燕,王春梅,姜涛,等.干细胞因子在正常及梗死心肌中的表达[J].中国介入心脏病学杂志,2004,12(5)：297-300.
[36]王立新,王奇,石海燕,等.骨髓干细胞动员治疗急性心肌梗死[J].中国比较医学杂志,2007,17(5)：249-252.
[37]冼绍祥,杨忠奇,汪朝晖,等.黄芪甲苷体外诱导骨髓间充质干细胞分化为心月几样细胞的实验研究[J].广州中医药大学学报,2007,24(1)：37-40.
[38]范英昌,华生瑜,姚雅娟.丹酚酸B诱导体外培养大鼠骨髓基质细胞向心肌样细胞分化的研究[J].天津中医学院学报,2005,24(1)：10-12.
[39]宋清,张晓文,卢新政,等.参三七皂苷Rgl预适应对5-氮胞苷诱导大鼠骨髓间充质干细胞向心肌细胞转化的干预[J].中国组织工程研究与临床康复,2007,11(24)：4693-469.
[40]曾意荣,樊粤光,刘红,等.补肾活血中药对大鼠骨髓间充质干细胞体外增殖的影响[J].中国组织工程研究与临床康复,2008,12(8)：1545-1547.
[41]李连达,张荣利,刘成源,等.双龙方与自体骨髓单个核细胞经心导管移植对中国小型猪心肌梗死的影响[J].中国新药杂志,2003,12(12)：999-1003.
[42]倪玉霞,刘小青,李贻奎,等.骨髓间充质干细胞移植联合冠心Ⅱ号对大鼠急性心肌梗死心功能和血管新生的影响.中国组织工程与临床康复,2008,12(47)：9201-9209.
[43]李广斌,苏金玲,姜希娟,等.中药心复康在大鼠急性心肌梗塞后对移植骨髓间充质干细胞的保护作用[J].时珍国医国药,2009,20(12)：3043-3045.
[44]李广斌,苏金玲,姜希娟,等.中药心复康联合骨髓间充质干细胞移植对大鼠急性心肌梗死后心功能的影响[J].天津中医药大学学报,2009,28(2)：78-80.
[45]钟鸣,苏海.心肌损伤时复方丹参滴丸的骨髓动员作用[J].浙江中西医结合杂志,2008,18(9)：529-531.